Publications of Udo Reichl

Dogra, T., Pelz, L., Rüdiger, D., Hein, M. D., Baelkner, M., Julia D. Boehme, J. D., Marichal-Gallardo, P., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccinationPresented at: 8^th European Congress of VirologyGdańsk (Poland), May 4, 2023.

Hoang Son, T., Lange, F., Rexer, T., & Reichl, U.Multi-gram-scale production of uridine nucleotide sugars by in-vitro multi-enzyme cascadesPresented at: GlycoBioTec 2023Berlin, Germany, January 17, 2023.

Hoang Son, T., Wormstall, S.-T., Rexer, T., & Reichl, U.Development of an in-vitro multi-enzyme cascade for the synthesis of uridine diphosphate N-acetylgalactosamine using a DoE approachPresented at: GlycoBioTec 2023Berlin, Germany, January 17, 2023.

Juárez-Osorio, M., Darr, A., Volckmar, J., Bruder, D., Rexer, T., & Reichl, U.Towards full control over protein glycosylation: in-vitro glycoengineering of influenza A virus hemagglutinin and SARS-CoV-2 spike proteinPresented at: GlycoBioTec 2023Berlin, Germany, January 16, 2023.

Küchler, J., Opitz, P., Kupke, S. Y., Genzel, Y., Benndorf, D., & Reichl, U.Absolute quantification of viral proteins during single-round replication of vaccine producer cell linesPresented at: 32^nd Annual Meeting of the Society for Virology (GfV) Ulm (Germany), March 28, 2023.

Küchler, J., Opitz, P., Kupke, S. Y., Genzel, Y., Benndorf, D., & Reichl, U.Absolute quantification of influenza A virus proteins during single-round replication in vaccine producer cell linesPresented at: 16^th PEACe (Protein Expression in Animal Cells) ConferenceSitges (Spain), September 24, 2023.

Lemke, G., Zuniga-Banuelos, F. J., Grote, V., Hoffmann, M., Rapp, E., & Reichl, U.N-glycan Sulfation on Human IgA: In-Depth N-glycoproteomic Analyses of Sulfated N-glycan Site-Specificity and Distribution on Human IgA IsotypesPresented at: GlycoBioTec 2023Berlin, Germany, January 17, 2023.

Pelz, L., Dogra, T., Boehme, J. D., Hein, M. D., Marichal-Gallardo, P., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Influenza A virus OP7 defective interfering particles: Cell culture-based production and antiviral efficacy in vivoPresented at: Cell Culture Engineering (CCE) XVIII Cancun (Mexico), April 23, 2023.

Pelz, L., Dogra, T., Boehme, J. D., Marichal-Gallardo, P., Hein, M. D., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.A Scalable High-Yield Process for Production of Influenza A Virus Defective Interfering Particles and In Vivo StudiesPresented at: Himmelfahrtstagung on Bioprocess Engineering 2023Weimar (Germany), May 15, 2023.

Pelz, L., Dogra, T., Boehme, J. D., Marichal-Gallardo, P., Hein, M. D., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Influenza A Virus Chimeric OP7 Defective Interfering Particles: Cell Culture-based Production and In Vivo Antiviral EfficacyPresented at: 32^nd Annual Meeting of the Society for Virology (GFV)Ulm (Germany), March 25, 2023.

Piasecka, J., Rüdiger, D., Kupke, S. Y., & Reichl, U.Reduced transcription of the mutated genomic segment 7 of the novel “OP7” influenza defective interfering particle intended for use as an antiviralPresented at: 8^th European Congress of VirologyGdańsk (Poland), May 4, 2023.

Piasecka, J., Rüdiger, D., Kupke, S. Y., & Reichl, U.Promoter mutations in novel “OP7” influenza defective interfering particle severely reduce transcription of its genomic segment 7Presented at: 32^nd Annual Meeting of the Society for Virology (GfV)Ulm (Germany), March 28, 2023.

Piasecka, J., Rüdiger, D., Kupke, S. Y., & Reichl, U.Promoter mutations in the novel “OP7” influenza defective interfering particle intended for use as antiviralPresented at: 17^th Vaccine CongressGlasgow (Scotland), September 24, 2023.

Rexer, T., Alcalá Orozco, E. A., Hoang Son, T., Kleeberg, S., & Reichl, U.Platform for the scalable synthesis of human milk oligosaccharidesPresented at: The Origins and Benefits of Biologically Active Components in Human Milk ConferenceFlorida, USA, June 4, 2023.

Sultan Mohideen, M. A. H., Khesali Aghtaei, H., Reichl, U., & Benndorf, D.Development of a packed foam bed bioreactor for biological methanationPresented at: 6th International Conference on Monitoring and Control of Anaerobic Digestion ProcessesLeipzig, Germany, March 22, 2023.

Wenzel, L., Ruhnau, J., Hoffmann, M., Rexer, T., & Reichl, U.Synthesis of Synthetic Lipid-Linked Oligosaccharides for In-Vitro Glycoengineering of Hemagglutinin Peptides by a Cell-Free, Multi-Enzyme CascadePresented at: GlycoBioTec 2023Berlin, Germany, January 14, 2023.

Zuniga-Banuelos, F. J., Hoffmann, M., Budimir, I., Reichl, U., & Rapp, E.New avenues for human blood plasma biomarker discovery via improved in-depth analysis of the low-abundant N-GlycoproteomePresented at: GlycoBioTec 2023Berlin, Germany, January 17, 2023.

Alcalá Orozco, E. A., Hoang Son, T., Rexer, T., & Reichl, U.In vitro multi-enzyme cascades for the synthesis of nucleotide sugarsPresented at: INTERfaces Conference on ‘Intensifying Biocatalytic Processes – From Enzyme and Material Design to Industrial Applications’ (IBPRO2022)Bielefeld, Germany, March 28, 2022.

Dogra, T., Pelz, L., Marc, H., Rüdiger, D., Boehme, J., Bruder, D., Kupke, S. Y., & Reichl, U.Reverse genetics for Influenza A virus to generate genetically engineered defective interfering particles for antiviral treatment and vaccinationPresented at: 27th ESACT MeetingLisbon (Portugal), June 26, 2022.

Göbel, S., Dorn, M., Jaén Chavez, K., Jordan, I., Sandig, V., Altomonte, J., Genzel, Y., & Reichl, U.Production of a fusogenic oncolytic rVSV-NDV virus in perfusion processesPresented at: Vaccine Technology VIIISitges (Spain), June 12, 2022.